maria-mohlen
Restylane is not only about beauty. I can see that our products bring in so many other values in people’s lives as well.
Maria Molén Training & Account Manager Nordic countries

Products

img-spot

Career

img-spot

Press

img-spot

A GLOBAL LEADER IN AESTHETIC AND CORRECTIVE TREATMENTS

Q-Med, a Galderma division, develops, manufactures and markets solutions for aesthetic and corrective treatments.

The division offers a complete worldwide portfolio in the aesthetic field including the brands Restylane, Emervel. Deflux, Solesta and Durolane are other products improving patients’ health in the corrective field.

Since 2011, Q-Med is wholly owned by Galderma, a pharmaceutical company with nearly 4 000 employees specialized in dermatology and present in more than 70 countries. The site in Uppsala, Sweden, is  Galderma’s Global Aesthetic Center of Excellence with world-class research and development and manufacturing.

For more information about Galderma, please visit www.galderma.com

 

 Visit Restylane
 Visit Emervel
 Visit Macrolane

News

2012-05-16 Office closed Q-Med´s office will be closed the following days: Thursday May, 17 Friday May, 18 Read more
2012-04-18 Q-Med provides update on the use of Macrolane Q-Med has decided to discontinue the breast indication for Macrolane until consensus for best practices in breast radiology examination following Macrolane treatment has been reached. Read more
2012-04-04 New employees now being taken on by Q-Med Article in Uppsala Bio Read more
2011-12-21 Restylane on Facebook Did you know that we have a global Restylane page on Facebook? Read more
Archive